Literature DB >> 17388169

Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions.

Aaron C Spalding1, Kyung-Wook Jee, Karen Vineberg, Marla Jablonowski, Benedick A Fraass, Charlie C Pan, Theodore S Lawrence, Randall K Ten Haken, Edgar Ben-Josef.   

Abstract

Radiotherapy for pancreatic cancer is limited by the tolerance of local organs at risk (OARs) and frequent overlap of the planning target volume (PTV) and OAR volumes. Using lexicographic ordering (LO), a hierarchical optimization technique, with generalized equivalent uniform dose (gEUD) cost functions, we studied the potential of intensity modulated radiation therapy (IMRT) to increase the dose to pancreatic tumors and to areas of vascular involvement that preclude surgical resection [surgical boost volume (SBV)]. We compared 15 forward planned three-dimensional conformal (3DCRT) and IMRT treatment plans for locally advanced unresectable pancreatic cancer. We created IMRT plans optimized using LO with gEUD-based cost functions that account for the contribution of each part of the resulting inhomogeneous dose distribution. LO-IMRT plans allowed substantial PTV dose escalation compared with 3DCRT; median increase from 52 Gy to 66 Gy (a=-5,p<0.005) and median increase from 50 Gy to 59 Gy (a=-15,p<0.005). LO-IMRT also allowed increases to 85 Gy in the SBV, regardless of a value, along with significant dose reductions in OARs. We conclude that LO-IMRT with gEUD cost functions could allow dose escalation in pancreas tumors with concomitant reduction in doses to organs at risk as compared with traditional 3DCRT.

Entities:  

Mesh:

Year:  2007        PMID: 17388169     DOI: 10.1118/1.2426403

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  16 in total

Review 1.  Chemoradiotherapy for unresectable pancreatic cancer.

Authors:  Edgar Ben-Josef; Theodore S Lawrence
Journal:  Int J Clin Oncol       Date:  2008-05-08       Impact factor: 3.402

Review 2.  Recent progress in pancreatic cancer.

Authors:  Christopher L Wolfgang; Joseph M Herman; Daniel A Laheru; Alison P Klein; Michael A Erdek; Elliot K Fishman; Ralph H Hruban
Journal:  CA Cancer J Clin       Date:  2013-07-15       Impact factor: 508.702

3.  A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.

Authors:  Edgar Ben-Josef; Mathew Schipper; Isaac R Francis; Scott Hadley; Randall Ten-Haken; Theodore Lawrence; Daniel Normolle; Diane M Simeone; Christopher Sonnenday; Ross Abrams; William Leslie; Gazala Khan; Mark M Zalupski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-27       Impact factor: 7.038

4.  Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer.

Authors:  Karyn A Goodman; William F Regine; Laura A Dawson; Edgar Ben-Josef; Karin Haustermans; Walter R Bosch; Julius Turian; Ross A Abrams
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-05       Impact factor: 7.038

5.  Multicriteria optimization in intensity-modulated radiation therapy treatment planning for locally advanced cancer of the pancreatic head.

Authors:  Theodore S Hong; David L Craft; Fredrik Carlsson; Thomas R Bortfeld
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-15       Impact factor: 7.038

6.  Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.

Authors:  Wenjie Sun; Cheng N Leong; Zhen Zhang; Jiade J Lu
Journal:  Radiat Oncol       Date:  2010-04-15       Impact factor: 3.481

Review 7.  Intensity-modulated radiation therapy for gastrointestinal tumors.

Authors:  Jeffrey J Meyer; Brian G Czito; Christopher G Willett
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

8.  Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution.

Authors:  Mary Feng; James M Balter; Daniel Normolle; Saroja Adusumilli; Yue Cao; Thomas L Chenevert; Edgar Ben-Josef
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-22       Impact factor: 7.038

9.  Comparison of four target volume definitions for pancreatic cancer. Guidelines for treatment of the lymphatics and the primary tumor.

Authors:  E Fokas; C Eccles; N Patel; K-Y Chu; S Warren; W Gillies McKenna; T B Brunner
Journal:  Strahlenther Onkol       Date:  2013-04-05       Impact factor: 3.621

10.  Endobiliary stent: marker for patient alignment in image-guided radiotherapy in pancreatic and periampullary cancers.

Authors:  Pragya Shukla; Reena Engineer; Supriya Chopra; Shyam Kishore Shrivastava
Journal:  J Gastrointest Cancer       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.